Reference
- Kampa-Schittenhelm KM, et al. Dasatinib overrides the differentiation blockage in a patient with mutant-KIT D816V positive CBFbeta-MYH11 leukemia. Oncotarget 9: 11876-11882, No. 14, 20 Feb 2018. Available from: URL: http://doi.org/10.18632/oncotarget.24376 - Germany
Copyright information
© Springer International Publishing AG, part of Springer Nature 2018